Search:

Start a new search
Add/Remove Filters (3 filters currently applied)

Results 1-10 of 10 (Search time: 0.049 seconds).
 |  Relevance

 

  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
12015Influence of CYP3A polymorphisms on the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male ChineseChan, Stella Sze Wa 
22016Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β‐hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male ChineseChan, Stella Sze Wa 
32021Influence of CYP2D6 and CYP3A5 polymorphisms on the pharmacokinetics and pharmacodynamics of bisoprolol in hypertensive Chinese patientsChan, Stella Sze Wa 
42022Lack of effects of renin-angiotensin-aldosterone system activity and beta-Adrenoceptor pathway polymorphisms on the response to isoprolol in hypertensionChan, Stella Sze Wa 
52021Impact of short-term bilberry supplementation on glycemic control, cardiovascular disease risk factors, and antioxidant status in Chinese patients with type 2 diabetesChan, Stella Sze Wa 
62012Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjectsChan, Stella Sze Wa 
72012Simultaneous determination of cortisol, cortisone, and 6 β-hydroxycortisol in human urine by UPLC with UV detector and application to determine diurnal variationsChan, Stella Sze Wa 
82017Effect of bilberry (Vaccinium myrtillus) supplementation on cardiovascular risk factors and glycaemic control in Chinese type 2 diabetic patientsChan, Stella Sze Wa 
92011Electrocardiographic effects and plasma concentrations of flecainide and propafenone in healthy Chinese subjectsChan, Stella Sze Wa 
102011Flecainide pharmacokinetics are influenced by CYP3A5 and ABCB1 polymorphismsChan, Stella Sze Wa